Clinical measurement of blood flow in tumours using positron emission tomography: A review

Nuclear Medicine Communications

Volumn 23, Issue 2, 2002, Pages 131-138

  Anderson, H ^a   Price, P ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Positron emission tomography; Tumour blood flow

Indexed keywords

ANIMAL EXPERIMENT; CANCER CHEMOTHERAPY; DIAGNOSTIC VALUE; HEMODYNAMIC MONITORING; HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; REVIEW; TREATMENT OUTCOME; TUMOR BLOOD FLOW;

BREAST NEOPLASMS; CEREBROVASCULAR CIRCULATION; CORONARY CIRCULATION; GASTROINTESTINAL NEOPLASMS; HUMANS; MODELS, CARDIOVASCULAR; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036099568     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200202000-00004     Document Type: Article

References (52)

1. Deplanque G, Harris AL. Anti-angiogenic agents. Clinical trial design and therapies in development. Eur J Cancer 2000; 36: 1713-1724.
2. Wootton R. Theory of blood flow measurement with tracers. In: Mathie RT, ed. Blood flow measurement in man. London: Castle House Publications, 1982: 3-13.
3. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951; 3: 1-41.
4. Landau WM, Freygang WH, Roland LP et al. The local circulation of the living brain: Values in the unanesthetized and anesthetized cat. Trans Am Neurol Assoc 1955; 80: 125-129.
5. Kety SS. Measurement of local contribution within the brain by means of inert, diffusible tracers; examination of the theory, assumptions and possible sources of error. Acta Neurol Scand Suppl 1965; 14: 20-23.
6. Ter-Pogossian MM, Eichling JO, Davis DO et al. The determination of regional cerebral blood flow by means of water labelled with radioactive oxygen 15. Radiology 1969; 93: 31-40.
7. Ter-Pogossian MM, Eichling JO, Davis DO et al. The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. J Clin Invest 1970; 49: 381-391.
8. 15O). Br J Radiol 1976; 49: 393-397.
9. Kaplan E, Mayron LW, Friedman AM et al. Definition of myocardial perfusion by continuous infusion of krypton-81m. Am J Cardiol 1976; 37: 878-884.
10. Fazio F, Nardini M, Fieschi C et al. Assessment of regional cerebral blood flow by continuous carotid infusion of krypton-81m. J Nucl Med 1977; 18: 962-966.
11. Harf A, Hughes JM. Topographical distribution of VA/Q in elderly subjects using krypton-81m. Respir Physiol 1978; 34: 319-327.
12. Selwyn AP, Jones T, Turner H et al. Continuous assessment of regional myocardial perfusion in dogs using krypton-81m. Circ Res 1978; 42: 771-777.
13. Huang SC, Phelps ME, Hoffman EJ et al. A theoretical study of quantitative flow measurements with constant infusion of short-lived isotopes. Phys Med Biol 1979; 24: 1151-1161.
14. 2. J Nucl Med 1978; 19: 48-53.
15. 2(15)O. I. Theory and error analysis. J Nucl Med 1983; 24: 782-789.
16. Frackowiak RS, Jones T, Lenzi GL et al. Regional cerebral oxygen utilization and blood flow in normal man using oxygen-15 and positron emission tomography. Acta Neurol Scand 1980; 62: 336-344.
17. Lenzi GL, Frackowiak RS, Jones T et al. CMRO2 and CBF by the oxygen-15 inhalation technique. Results in normal volunteers and cerebrovascular patients. Eur Neurol 1981; 20: 285-290.
18. Lammertsma AA, Jones T, Frackowiak RS et al. A theoretical study of the steady-state model for measuring regional cerebral blood flow and oxygen utilisation using oxygen-15. J Comput Assist Tomogr 1981; 5: 544-550.
19. Lammertsma AA, Jones T. Low oxygen extraction fraction in tumours measured with the oxygen-15 steady state technique: effect of tissue heterogeneity. Br J Radiol 1992; 65: 697-700.
20. 15O-labeled carbon dioxide and positron emission tomography. J Comput Assist Tomogr 1982; 6: 116-124.
21. Wilson CB, Lammertsma AA, McKenzie CG et al. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. Cancer Res 1992; 52: 1592-1597.
22. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980; 4: 727-736.
23. 2 reactivity in the anaesthetised dog. J Neurol Sci 1981; 50: 381-389.
24. 2 steady-state method, and positron emission tomography. Acta Neurol Scand 1996; 73: 415-422.
25. Huang SC, Schwaiger M, Carson RE et al. Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. J Nucl Med 1985; 26: 616-625.
26. 15O. Circulation 1984; 70: 724-733.
27. 15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993; 87: 512-525.
28. Araujo LI, Lammertsma AA, Rhodes CG et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991; 83: 875-885.
29. Muzik O, Beanlands RS, Hutchins GD et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993; 34: 83-91.
30. Ruotsalainen U, Raitakari M, Nuutila P et al. Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med 1997; 38: 314-319.
31. 15O-labeled water. Kidney Int 2000; 57: 2511-2518.
32. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-6465.
33. Mineura K, Sasajima T, Itoh Y et al. Blood flow and metabolism of central neurocytoma: a positron emission tomography study. Cancer 1995; 76: 1224-1232.
34. Mineura K, Sasajima T, Kowada M et al. [Positron emission tomography (PET) study in patients with meningiomas.] No To Shinkei 1990; 42: 145-151.
35. 18F-fluorodeoxyglucose. J Neurooncol 1999; 43: 49-57.
36. Lassen U, Andersen P, Daugaard G et al. Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography. Clin Cancer Res 1998; 4: 2591-2597.
37. Mizukawa N, Hino A, Imahori Y et al. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues.] No To Shinkei 1989; 41: 251-258.
38. Lammertsma AA, Wise RJ, Cox TC et al. Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br J Radiol 1985; 58: 725-734.
39. Beaney RP, Lammertsma AA, Jones T et al. Positron emission tomography for in vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet 1984; i: 131-134.
40. Kubo S, Yamamoto K, Magata Y et al. Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water. Ann Nucl Med 1991; 5: 133-138.
41. Taniguchi H, Koyama H, Masuyama M et al. Angiotensin-II-induced hypertension chemotherapy: evaluation of hepatic blood flow with oxygen-15 PET. J Nucl Med 1996; 37: 1522-1523.
42. Yamaguchi A, Taniguchi H, Kunishima S et al. Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma. Cancer 2000; 89: 1236-1244.
43. Anderson H, Yap J, Price P. Measurement of tumour and normal tissue (NT) perfusion by positron emission tomography (PET) in the evaluation of antivascular therapy: Results in the Phase I study of Combretastatin A4 Phosphate (CA4P). Proc Am Soc Clin Oncol 2000; 19: 695.
44. Tozer GM, Prise VE, Wilson J et al. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Cancer Res 1999; 59: 1626-1634.
45. Young H, Carnochan P, Zweit J et al. Tissue blood flow estimation with copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) and PET. J Nucl Biol Med 1994; 38: 89-91.
46. Mathias CJ, Green MA, Morrison WB et al. Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms. Nucl Med Biol 1994; 21: 83-87.
47. 13N-ammonia uptake in myocardial single cells indicating potential limitations in its applicability as a marker of myocardial blood flow. Circulation 1985; 71: 387-393.
48. Rowell NP, Flower MA, McCready VR et al. The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol 1990; 18: 283-292.
49. Nasu R, Kimura H, Akai M et al. Analysis of intermittent blood flow in experimental tumor using a transparent chamber. Gan To Kagaku Ryoho 1999; 26: 667-672.
50. Burrows FJ, Derbyshire EJ, Tazzari PL et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1995; 1: 1623-1634.
51. Carroll VA, Glaser M, Aboagye EO et al. Imaging vascular endothelial growth factor in vivo with positron emission tomography. Br J Cancer 2000; 83: 30.
52. Sasajima T, Mineura K, Kowada M, Shishido F, Uemura K. Analysis of regional blood flow, blood volume, oxygen and glucose metabolism in heterogeneous parts of untreated high grade gliomas using positron emission tomography (PET) No Shinkel Geka 1989 Nov; 17(11): 1005-1013.